OncLive SOSS

My Treatment Approach: Graft vs Host Disease - Episode 9

Tailored Conditioning Regimens for Patients with GVHD Receiving Allogeneic Transplant

April 13, 2023

Pashna Munshi, MD

Pashna Munshi, MD, details how age and risk factors into her choice of conditioning regimen for patients with GVHD receiving allogeneic transplant.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

EP. 1: Patient Profile Presentation: A 60-Year-Old Man with Graft-Versus-Host Disease (GVHD)

EP. 2: Staging of Chronic GVHD

EP. 3: First-Line Treatment Options for Patients with Chronic GVHD

EP. 4: Patient Profile Presentation: A 67-Year-Old Woman with GVHD

EP. 5: Investigational Systemic Treatment Options for GVHD

EP. 6: Treatment Sequencing and Future of GVHD

EP. 7: Patient Profile Presentation: A 44-Year-Old Woman With Acute Myeloid Leukemia and Graft-Versus-Host Disease (GVHD)

EP. 8: Indications for Allogeneic Stem Cell Transplantation in the Treatment of Myeloid Malignancies

EP. 9: Tailored Conditioning Regimens for Patients with GVHD Receiving Allogeneic Transplant

EP. 10: Currently Available Options for GVHD Prophylaxis

EP. 11: Comparing Acute and Chronic GVHD

EP. 12: Available Frontline Treatment Options for Patients With Acute GVHD

EP. 13: Current Treatment Options for Patients with Steroid-Refractory Acute GVHD

x